Phyton Biotech® Launches New Video on its Specialty Fermentation Solutions
Watch the video now to learn more about Plant Cell Fermentation Technology®
Watch the video now to learn more about Plant Cell Fermentation Technology®
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
AqVida and Phyton Biotech Receive Approval from European Directorate of Quality Medicines.
Phyton Biotech partners with PellePharm.
Agenus’ R&D Project Funded by Bill & Melinda Gates Foundation Employs PCF® Technology for Potent Vaccine Ingredient
Phyton Biotech is pleased to announce the promotion of Bryan Radu to General Manager.
DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of Colin Marr to President of Phyton Ltd.
Phyton Biotech Wins Grant to Develop New Approaches to Manufacturing Artemisinin Bill & Melinda Gates Foundation Invests in R&D Pilot for Anti-Malarial Active Pharmaceutical Ingredients AHRENSBURG, [...]
Phyton Biotech showcased plant cell fermentation at CPhI Worldwide NOVEMBER 9, 2017 This October, Phyton Biotech attended CPhI Worldwide to exhibit its capabilities and the wide [...]
Phyton Biotech Achieves Manufacturing Milestone with Thapsigargin, the Active Agent in Mipsagargin AHRENSBURG, Germany--(BUSINESS WIRE)--Phyton Biotech today announced that it has achieved a major milestone in connection [...]